Journal
Journal for ImmunoTherapy of Cancer
Publication Date
11-30-2022
Volume
10
Issue
11
First Page
e005732
Document Type
Open Access Publication
DOI
10.1136/jitc-2022-005732
Rights and Permissions
Cortellini A, Dettorre GM, Dafni U, et alImmune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registriesJournal for ImmunoTherapy of Cancer 2022;10:e005732. doi: 10.1136/jitc-2022-005732 © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made.
Recommended Citation
Cortellini, Alessio; Dettorre, Gino M; and et al., "Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries." Journal for ImmunoTherapy of Cancer. 10, 11. e005732 (2022).
https://digitalcommons.wustl.edu/oa_4/1073
Additional Links
Supplemental material is available for this article at publisher site.
